Diabetic energy
Pro Research Analysisby 
Searched over 200M research papers for "diabetic energy"
Consensus Meter
Diabetic Energy Expenditure and Metabolism
Increased Energy Expenditure in Type 1 Diabetes
Poorly controlled Type 1 diabetic patients exhibit significantly higher basal energy expenditure compared to predicted values based on age, sex, and body surface area. This increased metabolic rate is associated with elevated protein turnover and plasma glucagon levels, but not with cortisol, growth hormone, or triiodothyronine concentrations. Intravenous insulin treatment can normalize this elevated energy expenditure, aligning it with predicted values. The heightened energy expenditure in uncontrolled diabetic patients contributes to the weight loss commonly observed in these individuals.
Total Energy Expenditure in Type 2 Diabetes
Studies indicate that total energy expenditure (TEE) in patients with Type 2 diabetes is comparable to that of non-diabetic individuals when adjusted for factors such as body composition, physical activity level, sex, and age. This finding holds true across different populations, including Japanese and African-American cohorts. However, basal metabolic rate (BMR) tends to be slightly higher in diabetic patients, which may be attributed to differences in body composition and metabolic demands .
Energy Metabolism During Exercise
In Type 1 diabetic patients, fuel metabolism during aerobic exercise varies significantly between euglycemic and hyperglycemic states. During euglycemia, there is a shift towards lipid oxidation, similar to healthy individuals. Conversely, hyperglycemia leads to a predominance of carbohydrate oxidation, with higher intramyocellular glycogen levels and consumption. This metabolic shift underscores the importance of maintaining euglycemia to optimize energy utilization during physical activity.
Cellular Energy Sensing and AMPK Activation
The cellular energy sensor AMP-activated protein kinase (AMPK) plays a crucial role in maintaining energy homeostasis. Activation of AMPK through glucose-lowering therapies such as caloric restriction, exercise, and metformin enhances glucose uptake, fatty acid oxidation, and mitochondrial function while suppressing lipid synthesis and inflammation. Targeting AMPK activation presents a promising therapeutic strategy for managing diabetes and its complications by ensuring efficient energy utilization and reducing metabolic stress .
Energy Restriction and Diabetes Management
Energy restriction (ER) has been shown to prevent the development of Type 2 diabetes in animal models by improving metabolic parameters and altering gene expression related to glucose and lipid metabolism. In clinical settings, both intermittent and continuous energy restriction diets have been effective in reducing HbA1c levels and promoting weight loss in Type 2 diabetic patients. These dietary interventions offer viable alternatives for glycemic control and weight management, with intermittent energy restriction providing a flexible approach for patients .
Cardiac Energy Metabolism in Diabetic Patients
In diabetic hearts, there is a notable shift in energy substrate utilization. Diabetic patients exhibit decreased myocardial uptake of glucose, lactate, and pyruvate, while reliance on ketone bodies as an energy source increases. This adaptation may partially compensate for impaired glucose metabolism, highlighting the metabolic flexibility of the diabetic heart in response to altered nutrient availability.
Conclusion
Diabetes significantly impacts energy expenditure and metabolism, with variations observed between Type 1 and Type 2 diabetes. Understanding these metabolic changes is crucial for developing effective management strategies, including optimizing insulin therapy, dietary interventions, and targeting key metabolic pathways such as AMPK activation. These approaches can help improve energy utilization, glycemic control, and overall metabolic health in diabetic patients.
Sources and full results
Most relevant research papers on this topic